Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Noninvasive Prenatal Screening by Next-Generation Sequencing

21 May 2014

Abstract excerpt

Noninvasive prenatal screening (NIPS) has emerged as a highly accurate method of screening for fetal Down syndrome, with a detection rate and specificity approaching 100%. Challenging the widespread use of this technology are cost and the paradigm shift in counseling that accompanies any emerging technology. The expense of the test is expected to decrease with increased utilization, and well beyond the current...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal and Pediatric Neurological Disorders
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24849140
DOI: 10.1146/annurev-genom-090413-025341

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Noninvasive Prenatal Screening by Next-Generation SequencingPMID 24849140Read ↗

Noninvasive prenatal diagnosis empowered by high‐throughput sequencingSemantic proximity Read ↗

International Society for Prenatal Diagnosis Updated Position Statement on the use of genome‐wide sequencing for prenatal diagnosisSemantic proximity Read ↗

Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011Semantic proximity Read ↗

Advancements in Prenatal Genetics: Emerging Technologies and Evolving ApplicationsSemantic proximity Read ↗

Next-generation sequencing and the impact on prenatal diagnosisSemantic proximity Read ↗

Advancements in Prenatal Genetic Screening and Testing: Emerging Technologies and Evolving ApplicationsSemantic proximity Read ↗

Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screeningSemantic proximity Read ↗

Noninvasive fetal genome sequencing: a primerSemantic proximity Read ↗

Prenatal genetic testing 2: diagnostic testsSemantic proximity Read ↗

Has Noninvasive Prenatal Testing Impacted Termination of Pregnancy and Live Birth Rates of Infants With Down Syndrome?Semantic proximity Read ↗

Non‐invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowlySemantic proximity Read ↗

Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome‐wide sequencing for fetal diagnosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.